Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 29.06.2026 2 Am J Kidney Dis 5 BMC Neurol 5 Diabetes 3 J Neuroimmunol 4 J Neurol 1 Lancet Neurol 3 Mult Scler 1 Nat Rev Neurol 1 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. AYOUB I, Coppock G, Wadhwani S, Yau T, et al
   KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
   Am J Kidney Dis. 2026;88:18-35.
   PubMed         Abstract available
   
   
2. 
   Erratum Regarding "The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease" (Am J Kidney Dis. 2024;83(1):79-89).
   Am J Kidney Dis. 2026;88:177-178.
   PubMed        
   
   

   
   BMC Neurol

3. LIU Y, Wang J, Sun M, Liu Y, et al
   Clinical characteristics and treatment of patients with overlapping MOG and anti-NMDAR encephalitis.
   BMC Neurol. 2025;25:472.
   PubMed         Abstract available
   
   
4. MAHLBERG M, Dorst J, Elmas Z, Haase U, et al
   Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysis.
   BMC Neurol. 2025;25:293.
   PubMed         Abstract available
   
   
5. QUAN M, Ren F, Sun T, Chang X, et al
   Adenylate kinase 5 autoimmune encephalitis following craniopharyngioma radiotherapy.
   BMC Neurol. 2026 Jun 25. doi: 10.1186/s12883-026-05090.
   PubMed         Abstract available
   
   
6. MAGHBOOLI Z, Nasir E, Mahdavinasab F, Sahraian MA, et al
   The HLA paradox across populations in multiple sclerosis progression: a systematic review.
   BMC Neurol. 2026 Jun 24. doi: 10.1186/s12883-026-05100.
   PubMed         Abstract available
   
   
7. FLINTERE-FLINTE A, Krutovs V, Pantelejeva E, Blennow K, et al
   Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation.
   BMC Neurol. 2026 Jun 20. doi: 10.1186/s12883-026-05024.
   PubMed         Abstract available
   
   

   
   Diabetes

8. DAO GM, Zhao S, Schofield C, Vogrin S, et al
   Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes.
   Diabetes. 2026 Apr 24:db260059. doi: 10.2337/db26-0059.
   PubMed         Abstract available
   
   
9. SORUM NE, Warnoe J, Holst JJ, Hartmann B, et al
   The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
   Diabetes. 2026 May 5:db251128. doi: 10.2337/db25-1128.
   PubMed         Abstract available
   
   
10. ONIZUKA S, Shinjo T, Ishikado A, Wu IH, et al
    Protection Against Periodontitis by Improving Mitochondrial Function in Diabetes.
    Diabetes. 2026 May 15:db250849. doi: 10.2337/db25-0849.
    PubMed         Abstract available
    
    
11. KOPRIVICA I, Jonic N, Dimitrijevic M, Jevtic B, et al
    Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.
    Diabetes. 2026 May 18:db250742. doi: 10.2337/db25-0742.
    PubMed         Abstract available
    
    
12. LI S, Wang J, Xin C, Dong Y, et al
    beta-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.
    Diabetes. 2026;75:1125-1141.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

13. ABDULRIDHA GAO, Fadhel AS, Al-Kinany SQ, Makki NF, et al
    Serum IDO1 and beta-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.
    J Neuroimmunol. 2026;419:579013.
    PubMed         Abstract available
    
    
14. FALSO S, De Maio MM, Marini S, Morcone V, et al
    Myasthenia gravis misdiagnosis in the era of innovative therapies: Uncovering pitfalls and patterns.
    J Neuroimmunol. 2026;419:579006.
    PubMed         Abstract available
    
    
15. DENIZ A, Ozer T, Balci S, Gunes AS, et al
    Brain volumetric changes in pediatric seronegative autoimmune encephalitis: A case-control study.
    J Neuroimmunol. 2026;419:579009.
    PubMed         Abstract available
    
    

    
    J Neurol

16. FREITAS-HUHTAMAKI A, Kleebauer N, Gardner A, Lundberg J, et al
    Screening 1021 Swedish memory clinic visitors for autoantibody-mediated encephalitis.
    J Neurol. 2026;273:408.
    PubMed         Abstract available
    
    
17. MUNOZ-VENDRELL A, Arroyo-Pereiro P, Leon I, Bau L, et al
    Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.
    J Neurol. 2026;273:412.
    PubMed         Abstract available
    
    
18. VISSING J, Pease S, Scippa K, Gandhi K, et al
    Health-related quality of life outcomes with nipocalimab versus placebo in generalized myasthenia gravis: an analysis of the Vivacity-MG3 study.
    J Neurol. 2026;273:423.
    PubMed         Abstract available
    
    
19. GANGEMI E, Piervincenzi C, Tommasin S, Ojha A, et al
    The relationship between cerebellar functional connectivity alterations and hand dexterity impairment in multiple sclerosis.
    J Neurol. 2026;273:425.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

20. LUNEMANN JD, Munz C
    Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
    Lancet Neurol. 2026 Jun 19:S1474-4422(26)00177.
    PubMed         Abstract available
    
    

    
    Mult Scler

21. AMATO MP, Portaccio E
    Cognitive impairment in multiple sclerosis: Where do we stand today?
    Mult Scler. 2026 Jun 23:13524585261457362. doi: 10.1177/13524585261457362.
    PubMed         Abstract available
    
    
22. LEE LE, Khoury M, Churchill N, Vavasour I, et al
    Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.
    Mult Scler. 2026 Jun 23:13524585261450926. doi: 10.1177/13524585261450926.
    PubMed         Abstract available
    
    
23. HUPPKE B, Reinert MC, Stark W, Gartner J, et al
    Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.
    Mult Scler. 2026 Jun 23:13524585261450816. doi: 10.1177/13524585261450816.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

24. VASSALLI A, Tafti M, Liblau RS
    Narcolepsy is (not) an autoimmune disease.
    Nat Rev Neurol. 2026 Jun 19. doi: 10.1038/s41582-026-01232.
    PubMed         Abstract available
    
    

    
    Neurology

25. MIRCHI A, Vossough A, Liu GT, Narula S, et al
    Pearls & Oy-sters: Radiologic Lag in Pediatric-Onset Multiple Sclerosis.
    Neurology. 2026;107:e218254.
    PubMed         Abstract available
    
    

    
    PLoS One

26. JAKOB ER, Amireault S, Reed JB, Kao SC, et al
    Potential intervention targets to promote physical activity among people with multiple sclerosis: A scoping review protocol for evidence of moderation.
    PLoS One. 2026;21:e0351882.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. KIM CD, Wang S, Placantonakis DG
    Modeling autoimmune encephalitis with the human hippocampus.
    Proc Natl Acad Sci U S A. 2026;123:e2615542123.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum